ACCO Brands Q2 Beat, but 2% Growth Signals a Slow Grind, Not a Rebound

ACCO Brands Beat Estimates, but the Growth Mix Still Matters

ACCO Brands delivered a clean beat: reported sales rose 5.1% to $415 million, adjusted EPS was $0.29, and management raised its full-year sales and EPS outlook. Still, the cleaner read is that ACCO looks like a better-than-feared turnaround, not a back-to-normal growth story. That matters because the stock is already near the top of their 52-week range.

What improved

The positive findings were real. The biggest driver was the Americas, where sales rose 6% and comparable sales increased 2%. Back-to-school placements were strong enough that management now expects back-to-school sales to grow in the mid-single digits for the full season.

Why the market is split

The bullish case is straightforward: ACCO is beating expectations, expanding margins, and holding onto cash-generation discipline. EPOS integration also remains on track, which helps the case for steadier execution.

The caution matters more. Comparable sales still fell, and headline growth was helped by EPOS and foreign exchange. Technology peripheral demand also remained weak, with management expecting that pressure to continue into the second half. In other words, ACCO looks healthier than feared, but it still needs execution and seasonal support to keep moving forward.

The Quarter Beat Real Demand, but Not a Broad Rebound

The quarter was a genuine beat, but the growth came from three different contributors rather than one broad demand rebound. Management said the 5.1% sales increase included 5.7% from the EPOS acquisition, 1.7% from favorable foreign exchange, and 2% from comparable sales decline in the underlying business. That is the key distinction: reported growth improved even as organic repeat demand softened.

The clearest operating win was in the Americas

In the Americas, sales rose 6% and comparable sales increased 2%. More important, Americas adjusted operating margin expanded 380 basis points to 21.2% on stronger volume and cost savings. That suggests the region is not only selling more, but also converting that activity into better profitability.

EPOS helps the numbers, but it is not a demand signal

EPOS is real added revenue, but it should be treated differently from organic demand. It supports the quarter and the outlook without proving that ACCO's legacy business has fully turned.

Why guidance can rise without a full recovery

Full-year guidance does not require every market to recover at once. It only requires enough regional strength, acquisition contribution, currency support, and cost discipline to protect earnings. That is why the raised outlook looks more credible than aggressive than expected. It is still a cautious setup.

The International note also matters for the next read. Management said the segment had shipment disruptions from a planned systems upgrade at its largest distribution center in EMEA, and that upgrade is now complete. If that disruption weighed on the quarter, the next comparison should look easier.

What improved: Americas volume, margin, and back-to-school momentum. What helped, but does not settle the thesis: EPOS revenue and cost savings. What still needs proof: International stabilization and broader organic demand outside the Americas.

Why the Raised Guidance Looks Disciplined, but Not Guaranteed

The raised outlook is constructive, but only in a disciplined sense. ACCO is not promising a dramatic demand rebound. It is aiming for reported sales growth of 2%–5% and adjusted EPS of $0.87–$0.91, while still targeting $75 million to $85 million of free cash flow. That reads more credible than an aggressive growth target because it is tied to cash generation and cost control, not to the assumption that every market will recover at once.

What the new numbers say

A 2%–5% reported sales range is more of a buffer than a trophy. It suggests management still sees modest top-line progress, but the bigger reassurance is in earnings and cash flow. If demand stays uneven, cost reductions and integration gains can still help defend the outlook.

The near-term test is seasonal follow-through

This is where the stock needs proof over the next few quarters. Management expects technology peripheral demand remained weak and that pressure to continue into the second half. At the same time, back-to-school is no longer just a placement story. Investors now need to see whether retail sell-through matches the optimism management already tied to the season. If the season holds, the outlook gets support. If it fades, the market will quickly focus on what is still not growing.

EPOS helps, but it does not replace a full turnaround

The EPOS acquisition matters because it adds revenue scale and potential earnings leverage. Management continues to target about $80 million of 2026 sales and $15 million in cost synergies within 18 months of closing. That helps explain why the company can raise profits before the legacy business looks fully recovered.

But acquisition contribution is not the same as a broad demand recovery. EPOS can support the guidance, but it cannot fully offset persistent weakness in tech peripherals on its own.

What Would Confirm the Bull Case-or Break It

The next few weeks matter because the market will judge ACCO by what sticks after the quarter closes.

Signals that would strengthen the case

• Americas momentum holds beyond placements. If sell-through was in line with or better than plan and the season still looks set for mid-single-digit back-to-school growth, bulls get evidence that the strongest part of the business is still gaining traction.
• Europe looks cleaner after the systems upgrade. If the system upgrade is now complete, investors should look for steadier shipments and fewer distribution-related disruptions.
• EPOS keeps integrating smoothly. If that trend continues, the acquisition starts to look like ongoing support rather than a one-quarter boost.

Signals that would weaken the case

• Tech peripherals stay soft. Management warned that technology peripheral demand remained weak and expected that pressure into the second half. If that weakness persists, more of the story will rest on cost control than on real demand recovery.
• Savings have to work harder to support the outlook. If cost reductions become the main thing keeping the guide intact, the turnaround case gets harder to defend.

For income-focused buyers, ACCO still has enough going for it: free cash flow of $75 million to $85 million, a cautious but workable guide, and a stock that is near the top of their 52-week range. That supports a "healthier than feared" setup. But this still looks like a slow grind rather than a clean growth rerating, and it still needs more organic proof.